These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
3. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P; Yeh ET Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046 [TBL] [Abstract][Full Text] [Related]
4. The role of resistin in obesity-induced insulin resistance. Haluzik M; Haluzikova D Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816 [TBL] [Abstract][Full Text] [Related]
5. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Black PH Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084 [TBL] [Abstract][Full Text] [Related]
6. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Filková M; Haluzík M; Gay S; Senolt L Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705 [TBL] [Abstract][Full Text] [Related]
7. Adipose tissue: a regulator of inflammation. Juge-Aubry CE; Henrichot E; Meier CA Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):547-66. PubMed ID: 16311216 [TBL] [Abstract][Full Text] [Related]
8. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. Ferrante AW J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176 [TBL] [Abstract][Full Text] [Related]
9. Role of resistin in obesity, insulin resistance and Type II diabetes. Kusminski CM; McTernan PG; Kumar S Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844 [TBL] [Abstract][Full Text] [Related]
11. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Koerner A; Kratzsch J; Kiess W Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Qatanani M; Lazar MA Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046 [TBL] [Abstract][Full Text] [Related]
13. The current biology of resistin. Steppan CM; Lazar MA J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878 [TBL] [Abstract][Full Text] [Related]
14. [Adipocytokins, obesity and development of type 2 diabetes]. Lacquemant C; Vasseur F; Leprêtre F; Froguel P Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899 [TBL] [Abstract][Full Text] [Related]
16. Role of resistin in inflammation and inflammation-related diseases. Pang SS; Le YY Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046 [TBL] [Abstract][Full Text] [Related]
17. Linking resistin, inflammation, and cardiometabolic diseases. Park HK; Kwak MK; Kim HJ; Ahima RS Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887 [TBL] [Abstract][Full Text] [Related]
18. Inflamed adipose tissue, insulin resistance and vascular injury. Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581 [TBL] [Abstract][Full Text] [Related]
19. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Tilg H; Moschen AR Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136 [TBL] [Abstract][Full Text] [Related]
20. Metabolic complications of obesity: inflated or inflamed? Chandalia M; Abate N J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]